Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery

Surgical Procedures, Operative Clinical Trial

— PREVEMCA  

Official title:

Impact of a Pharmacist-anesthesiologist Collaboration During Anesthesia Consultation on Prevention of Perioperative Medication Errors of Patients in Programmed Surgery

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04013061
• Other study ID #: PHRCI/2018/GL-01
• Status: Completed
• Start date: February 25, 2020
• Est. completion date: September 30, 2021

Study information

• Verified date: March 2022
• Source: Centre Hospitalier Universitaire de Nimes
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The investigators will evaluate the efficiency of a pharmacist-anesthesiologist collaboration in the anesthetic consultation in the prevention of medical errors perioperatively in patients undergoing scheduled surgery

Recruitment information / eligibility

• Status: Completed
• Enrollment: 378
• Est. completion date: September 30, 2021
• Est. primary completion date: August 20, 2021
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• The patient must have given their free and informed consent
• The patient must be a member or beneficiary of a health insurance plan
• The patient has at least one chronic medication prescription (associated with a chronic illness)
• The patient is hospitalized for a programmed surgery in the service of urology or digestive surgery at the CHU Nimes or orthopedic surgery in the CHU Montpellier or Toulouse

Exclusion Criteria:

• The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study
• The subject refuses to sign the consent
• It is impossible to give the subject informed information
• The patient is under safeguard of justice or state guardianship
• The patient is having ambulatory programmed surgery
• The patient has an anesthetic consultation in a different health establishment

Related Conditions & MeSH terms

• Surgical Procedures, Operative

Intervention

Other:
• Pluridisciplinary consultation
Pharmacist-anesthesiologist team will be present during the anesthetic consultation

Locations

Country	Name	City	State
France	CHU de Montpellier	Montpellier
France	CHU de Nimes	Nîmes
France	CHU de Toulouse	Toulouse

Sponsors (1)

Lead Sponsor	Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Rate of patients with at least one medication error for chronic treatment		48 hours post-admission
Secondary	Nature of medication error	According to REMED (Revue des Erreurs liées aux Médicaments Et Dispositifs médicaux) classification	48 hours post-admission
Secondary	Rate of medication errors corrected		48 hours post-admission
Secondary	Rate of prescriptions respecting the Société Française d'Anesthésie et de Réanimation recommendations		48 hours post-admission
Secondary	Rate of corrected medication errors or major, critical or catastrophic severity according to HAS 2018		48 hours post-admission
Secondary	Rate of patients whose usually prescribed medication at admission is not available for them in the evening following surgery		48 hours post-admission
Secondary	Rate of medications not available on the establishment's therapeutic book and not brought by the patient		48 hours post-admission
Secondary	Duration in hospital	Days	End of hospitalization (max 30 days)
Secondary	Rate of delay or cancellation of surgery linked to preoperational medication error		End of study (13 months)